Roles of gut microbiome in epilepsy risk: A Mendelian randomization study
BackgroundRecent studies have suggested an association between gut microbiomes (GMs) and epilepsy. However, the GM taxa identified in different studies are variable. In addition, observational studies cannot indicate causality. Therefore, our study aimed to explore the causal association of GMs with...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-02-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1115014/full |
| _version_ | 1797894007951458304 |
|---|---|
| author | Youjie Zeng Si Cao Heng Yang |
| author_facet | Youjie Zeng Si Cao Heng Yang |
| author_sort | Youjie Zeng |
| collection | DOAJ |
| description | BackgroundRecent studies have suggested an association between gut microbiomes (GMs) and epilepsy. However, the GM taxa identified in different studies are variable. In addition, observational studies cannot indicate causality. Therefore, our study aimed to explore the causal association of GMs with epilepsy and identify the most influential GM taxa.MethodsWe conducted a Mendelian randomization (MR) study using summary statistics from genome-wide association studies (GWAS) of 211 GM taxa and epilepsy. The GWAS summary statistics for 211 GM taxa (from phylum to genus level) were generated by the MiBioGen consortium, while the FinnGen consortium provided the GWAS summary statistics for epilepsy. The primary analytical method to assess causality was the inverse-variance weighted (IVW) approach. To complement the IVW method, we also applied four additional MR methods: MR-Egger, weighted median, simple mode, and weighted. In addition, we conducted sensitivity analyses using Cochrane’s Q-test, MR-Egger intercept test, MR-PRESSO global test, and leave-one-out analysis.ResultsWe evaluated the causal effect of 211 GM taxa (from phylum to genus level) on epilepsy, generalized epilepsy, and focal epilepsy. After using the Bonferroni method for multiple testing correction, Class Betaproteobacteria [odds ratio (OR) = 1.357, 95% confidence interval (CI): 1.126–1.635, p = 0.001] and Order Burkholderiales (OR = 1.336, 95% CI: 1.112–1.606, p = 0.002). In addition, 21 nominally significant causal relationships were also identified. Further, the MR-Egger intercept test and MR-PRESSO global test suggested that our MR analysis was unaffected by horizontal pleiotropy (p > 0.05). Finally, the leave-one-out analysis suggested the robustness of the results.ConclusionThrough the MR study, we analyzed the causal relationship of 211 GM taxa with epilepsy and determined the specific intestinal flora associated with increased epilepsy risk. Our findings may provide helpful biomarkers for disease progression and potential candidate therapeutic targets for epilepsy. In addition, in-depth analysis of large-scale microbiome GWAS datasets based on metagenomics sequencing is necessary for future studies. |
| first_indexed | 2024-04-10T07:01:57Z |
| format | Article |
| id | doaj.art-ac1d1dc4104b4706975c84ef6bc9018a |
| institution | Directory Open Access Journal |
| issn | 1664-302X |
| language | English |
| last_indexed | 2024-04-10T07:01:57Z |
| publishDate | 2023-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Microbiology |
| spelling | doaj.art-ac1d1dc4104b4706975c84ef6bc9018a2023-02-27T17:10:28ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-02-011410.3389/fmicb.2023.11150141115014Roles of gut microbiome in epilepsy risk: A Mendelian randomization studyYoujie Zeng0Si Cao1Heng Yang2Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Neurology, Third Xiangya Hospital, Central South University, Changsha, Hunan, ChinaBackgroundRecent studies have suggested an association between gut microbiomes (GMs) and epilepsy. However, the GM taxa identified in different studies are variable. In addition, observational studies cannot indicate causality. Therefore, our study aimed to explore the causal association of GMs with epilepsy and identify the most influential GM taxa.MethodsWe conducted a Mendelian randomization (MR) study using summary statistics from genome-wide association studies (GWAS) of 211 GM taxa and epilepsy. The GWAS summary statistics for 211 GM taxa (from phylum to genus level) were generated by the MiBioGen consortium, while the FinnGen consortium provided the GWAS summary statistics for epilepsy. The primary analytical method to assess causality was the inverse-variance weighted (IVW) approach. To complement the IVW method, we also applied four additional MR methods: MR-Egger, weighted median, simple mode, and weighted. In addition, we conducted sensitivity analyses using Cochrane’s Q-test, MR-Egger intercept test, MR-PRESSO global test, and leave-one-out analysis.ResultsWe evaluated the causal effect of 211 GM taxa (from phylum to genus level) on epilepsy, generalized epilepsy, and focal epilepsy. After using the Bonferroni method for multiple testing correction, Class Betaproteobacteria [odds ratio (OR) = 1.357, 95% confidence interval (CI): 1.126–1.635, p = 0.001] and Order Burkholderiales (OR = 1.336, 95% CI: 1.112–1.606, p = 0.002). In addition, 21 nominally significant causal relationships were also identified. Further, the MR-Egger intercept test and MR-PRESSO global test suggested that our MR analysis was unaffected by horizontal pleiotropy (p > 0.05). Finally, the leave-one-out analysis suggested the robustness of the results.ConclusionThrough the MR study, we analyzed the causal relationship of 211 GM taxa with epilepsy and determined the specific intestinal flora associated with increased epilepsy risk. Our findings may provide helpful biomarkers for disease progression and potential candidate therapeutic targets for epilepsy. In addition, in-depth analysis of large-scale microbiome GWAS datasets based on metagenomics sequencing is necessary for future studies.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1115014/fullgut microbiomeepilepsycausal relationshipincidence riskMendelian randomizationMiBioGen |
| spellingShingle | Youjie Zeng Si Cao Heng Yang Roles of gut microbiome in epilepsy risk: A Mendelian randomization study Frontiers in Microbiology gut microbiome epilepsy causal relationship incidence risk Mendelian randomization MiBioGen |
| title | Roles of gut microbiome in epilepsy risk: A Mendelian randomization study |
| title_full | Roles of gut microbiome in epilepsy risk: A Mendelian randomization study |
| title_fullStr | Roles of gut microbiome in epilepsy risk: A Mendelian randomization study |
| title_full_unstemmed | Roles of gut microbiome in epilepsy risk: A Mendelian randomization study |
| title_short | Roles of gut microbiome in epilepsy risk: A Mendelian randomization study |
| title_sort | roles of gut microbiome in epilepsy risk a mendelian randomization study |
| topic | gut microbiome epilepsy causal relationship incidence risk Mendelian randomization MiBioGen |
| url | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1115014/full |
| work_keys_str_mv | AT youjiezeng rolesofgutmicrobiomeinepilepsyriskamendelianrandomizationstudy AT sicao rolesofgutmicrobiomeinepilepsyriskamendelianrandomizationstudy AT hengyang rolesofgutmicrobiomeinepilepsyriskamendelianrandomizationstudy |